Protein clearance strategies for disease intervention.
Autor: | Hommen F; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph Stelzmann Strasse 26, 50931, Cologne, Germany., Bilican S; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph Stelzmann Strasse 26, 50931, Cologne, Germany., Vilchez D; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph Stelzmann Strasse 26, 50931, Cologne, Germany. dvilchez@uni-koeln.de.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. dvilchez@uni-koeln.de.; Faculty of Medicine, University Hospital Cologne, Cologne, Germany. dvilchez@uni-koeln.de. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2022 Feb; Vol. 129 (2), pp. 141-172. Date of Electronic Publication: 2021 Oct 23. |
DOI: | 10.1007/s00702-021-02431-y |
Abstrakt: | Protein homeostasis, or proteostasis, is essential for cell function and viability. Unwanted, damaged, misfolded and aggregated proteins are degraded by the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway. Growing evidence indicates that alterations in these major proteolytic mechanisms lead to a demise in proteostasis, contributing to the onset and development of distinct diseases. Indeed, dysregulation of the UPS or autophagy is linked to several neurodegenerative, infectious and inflammatory disorders as well as cancer. Thus, modulation of protein clearance pathways is a promising approach for therapeutics. In this review, we discuss recent findings and open questions on how targeting proteolytic mechanisms could be applied for disease intervention. (© 2021. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |